About the CompanyImmunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet patient needs in oncology, infectious diseases and autoimmune disease. Our leaders in R&D are internationally recognised as some of the biotech industry's most successful drug developers. We are creating not just an environment where great minds can interact but an innovation powerhouse answering the big questions.
Focused on delivering first-in-class biological therapies to patients, we have developed a highly innovative soluble TCR platform. Our ImmTAX molecules underpin a new generation of precision engineered drugs that harness the immune system to treat a broad spectrum of diseases with high unmet medical need, including oncology, infectious diseases and autoimmune diseases.
We strive to create a diverse and inclusive workplace, while seeking talented individuals to work with us across the many functions that will allow us to deliver new medicines to transform the lives of patients. You will work with outstanding people who together pioneer the research, development and commercialization of bi-specific TCR therapies. We aim to create an environment where individual contributions and initiatives can be maximized, while fostering a culture of collaboration, based on respect and integrity. We want each individual employee to own their career, as part of high-performing teams, and in the context of on-the-job and formal continuous development and training, as well as constructive feedback. We always strive to identify ways to improve what we do and how we do it, by asking questions, voicing opinions, exploring various approaches and staying connected with healthcare professionals, patients, academia and other key partners. Key ResponsibilitiesThis is a unique role to develop and lead the end-to-end lung cancer strategy across the portfolio for Immunocore, the only commercial stage T cell receptor company. The Lung Cancer Global Development Lead will report to the Chief Medical Officer and is primarily responsible for the strategy, design and execution of the early and late-stage lung clinical stage programs. The individual will also lead relevant health authority interactions and provide strategic lung cancer perspective to target discovery and translational medicine. They will lead cross functional lung cancer clinical trial teams, including clinical trial design and execution, data interpretation, and presentation. Key will be representing Immunocore externally and leading all interactions with a diverse range of global, scientific and clinical lung cancer experts. As Immunocore is a nimble commercial stage biotech, they must have a 'player-coach' mentality and be able and willing to balance leading a team strategically and, if needed, assume an individual contributor role on a protocol.
Lead the lung cancer strategy for Immunocore, from discovery through registration in close collaboration with other key leaders from Research, Regulatory, Portfolio Strategy, Translational Medicine, Medical Affairs and Commercial.
Serve as the internal lung cancer expert for the company.
Lead cross functional team(s) to design and execute innovative Ph1-3 lung cancer trials, from trial concept, site selection, data collection and analyses, ongoing safety review, clinical interpretation, publication and, where appropriate, regulatory submission.
Builds strong relationships with external lung experts, including SABs, collaborations and maintains high level and standard of scientific and clinical knowledge in lung cancer.
Complies with all governing laws and regulations, SOPs and any other guidelines as required.
This role may have supervisory duties associated with it and they are noted below:
Lead matrix clinical development teams comprised of indirect reports.
Oversight of direct report(s), including direction and support to ensure consistent approach and process to study execution and procedures amongst various program assets.
Experience & Knowledge:
At least 5 years biopharma experience, including experience in clinical trial development.
Expertise/deep understanding of the lung cancer landscape, including current and emerging treatments.
Designing and leading late phase lung cancer trials, including knowledge of relevant endpoints.
Leadership of matrix teams.
Established connections with global lung KOLs.
Working with relevant functions to develop a strategy.
Experience with health authority negotiations.
Participated in BLA/MAA.
Experience in Phase 1 and 2 clinical trials.
IO experience, including anti-PD(L)1.
Understanding of translational medicine and integration with IO development.
Demonstrated ability to prioritize in the face of multiple competing priorities.
Able to lead at least 3-5 Clinical trials of low to moderate complexity or 1-2 trials of high complexity.
Thorough understanding of clinical research methodology and biostatistics principles.
Must work with professional discretion and confidentiality.
Ability to work independently and think outside the box and problem-solve clinical trial issues.
Result and deadline orientated.
Excellent presentation skill.
Education & Qualifications:
Medical Degree with board certification (or equivalent) in oncology.
Expert in lung oncology clinical drug development.
Documented academic and/or clinical research publication history or history of medical practice in a medical field.
Training and experience working in Immunotherapy is highly desirable.
Strong working knowledge of the clinical drug development process with experience in the conduct/participation of clinical trials.
Demonstrated ability to critically evaluate medical/scientific information.
Subscribe to job alerts and upload your resume!
*By registering with our site, you agree to our